Gene · 638
Papers2,521
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,521
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation. | Front Oncol | 2022 | 35982976 | PubTator, text mining | PubMed |
| UBXD8 mediates mitochondria-associated degradation to restrain apoptosis and mitophagy. | EMBO Rep | 2022 | 35979733 | PubTator, text mining | PubMed |
| Daurisoline Inhibits ESCC by Inducing G1 Cell Cycle Arrest and Activating ER Stress to Trigger Noxa-Dependent Intrinsic and CHOP-DR5-Dependent Extrinsic Apoptosis via p-eIF2α-ATF4 Axis. | Oxid Med Cell Longev | 2022 | 35965681 | PubTator, text mining | PubMed |
| Targeting purine metabolism in ovarian cancer. | J Ovarian Res | 2022 | 35964092 | PubTator, text mining | PubMed |
| Mechanical Confinement and DDR1 Signaling Synergize to Regulate Collagen-Induced Apoptosis in Rhabdomyosarcoma Cells. | Adv Sci (Weinh) | 2022 | 35957513 | PubTator, text mining | PubMed |
| LncRNA H19 Impairs Chemo and Radiotherapy in Tumorigenesis. | Int J Mol Sci | 2022 | 35955440 | PubTator, text mining | PubMed |
| In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants. | J Genet Eng Biotechnol | 2022 | 35951173 | PubTator, text mining | PubMed |
| Pru du 1, the Bet v 1-homologue from almond, is a major allergen in patients with birch pollen associated almond allergy. | Clin Transl Allergy | 2022 | 35949989 | PubTator, text mining | PubMed |
| Molecular map of chronic lymphocytic leukemia and its impact on outcome. | Nat Genet | 2022 | 35927489 | PubTator, text mining | PubMed |
| Last but not least: BFL-1 as an emerging target for anti-cancer therapies. | Biochem Soc Trans | 2022 | 35900226 | PubTator, text mining | PubMed |
| The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype? | Ther Adv Hematol | 2022 | 35898435 | PubTator, text mining | PubMed |
| Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma. | Cancers (Basel) | 2022 | 35884390 | PubTator, text mining | PubMed |
| Insulin Directs Dichotomous Translational Regulation to Control Human Pluripotent Stem Cell Survival, Proliferation and Pluripotency. | Int J Biol Sci | 2022 | 35813470 | PubTator, text mining | PubMed |
| Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review. | Nutrients | 2022 | 35807785 | PubTator, text mining | PubMed |
| Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives. | Int J Mol Sci | 2022 | 35806271 | PubTator, text mining | PubMed |
| Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review. | Int J Mol Sci | 2022 | 35806184 | PubTator, text mining | PubMed |
| Effect of Enterococcus faecalis OG1RF on human calvarial osteoblast apoptosis. | BMC Oral Health | 2022 | 35804353 | PubTator, text mining | PubMed |
| Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. | Stem Cells Int | 2022 | 35800881 | PubTator, text mining | PubMed |
| Venetoclax resistance: mechanistic insights and future strategies. | Cancer Drug Resist | 2022 | 35800373 | PubTator, text mining | PubMed |
| Deconvolution analysis of cell-type expression from bulk tissues by integrating with single-cell expression reference. | Genet Epidemiol | 2022 | 35788983 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/638/papers?page=18